| 000 | 01784 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515063207.0 | ||
| 264 | 0 | _c20071220 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a0163-2116 | ||
| 024 | 7 |
_a10.1007/s10620-006-9720-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPetrovic, Bojan D | |
| 245 | 0 | 0 |
_aCorrelation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis. _h[electronic resource] |
| 260 |
_bDigestive diseases and sciences _cDec 2007 |
||
| 300 |
_a3499-506 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aCholangiopancreatography, Endoscopic Retrograde |
| 650 | 0 | 4 |
_aCholangiopancreatography, Magnetic Resonance _xmethods |
| 650 | 0 | 4 |
_aCholangitis, Sclerosing _xdiagnosis |
| 650 | 0 | 4 |
_aContrast Media _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGadolinium DTPA _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 700 | 1 | _aNikolaidis, Paul | |
| 700 | 1 | _aHammond, Nancy A | |
| 700 | 1 | _aMartin, John A | |
| 700 | 1 | _aPetrovic, Polina V | |
| 700 | 1 | _aDesai, Pankaja M | |
| 700 | 1 | _aMiller, Frank H | |
| 773 | 0 |
_tDigestive diseases and sciences _gvol. 52 _gno. 12 _gp. 3499-506 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10620-006-9720-1 _zAvailable from publisher's website |
| 999 |
_c16962502 _d16962502 |
||